Page last updated: 2024-11-05

trifluoperazine and Pulmonary Hypertension

trifluoperazine has been researched along with Pulmonary Hypertension in 2 studies

Research Excerpts

ExcerptRelevanceReference
" The in vivo therapeutic potential of TFP was tested in two preclinical models with established PAH, namely the monocrotaline and sugen/hypoxia-induced rat models."4.02Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension. ( Awada, C; Bonnet, S; Boucherat, O; Bourgeois, A; Breuils-Bonnet, S; Grobs, Y; Lemay, SE; Nadeau, V; Orcholski, M; Paulin, R; Provencher, S; Romanet, C; Shimauchi, K; Toro, V; Tremblay, E, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Grobs, Y1
Awada, C1
Lemay, SE1
Romanet, C1
Bourgeois, A1
Toro, V1
Nadeau, V1
Shimauchi, K1
Orcholski, M1
Breuils-Bonnet, S1
Tremblay, E1
Provencher, S1
Paulin, R1
Boucherat, O1
Bonnet, S1
Seeger, W1
Bauer, M1
Bhakdi, S1

Other Studies

2 other studies available for trifluoperazine and Pulmonary Hypertension

ArticleYear
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6

    Topics: Animals; Antipsychotic Agents; Cardiovascular Agents; Cell Proliferation; Disease Models, Animal; Dr

2021
Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.
    The Journal of clinical investigation, 1984, Volume: 74, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bacterial Toxins; Blood Pressure; Calcimycin; Calcium;

1984